Brivaracetam‐associated manic episode in a patient with bipolar disorder: A case report
Abstract Background Levetiracetam and brivaracetam (BRV) are antiseizure medications that exert effects by binding to synaptic vesicle protein 2A (SV2A). BRV exhibits higher affinity and selectivity for SV2A and is generally considered to have a favorable psychiatric tolerability profile. However, r...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2026-06-01
|
| Col·lecció: | PCN Reports |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/pcn5.70335 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|